NCT04970992
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
Clinical trial condition
Solid Tumor
Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.
717 public trials
251 recruiting studies
Solid Tumor trial results
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
NCT03013218
- Conditions
- Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- University of Colorado Denver Denver, Colorado, United States
- Yale University New Haven, Connecticut, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT05391022
- Conditions
- Advanced Malignancies, Hematologic Diseases, Hematologic Neoplasms, +5 more
- Locations
-
- Gabrail Cancer Center Research Canton, Ohio, United States
- Gettysburg Cancer Center Gettysburg, Pennsylvania, United States
- Start Mountain Region West Valley City, Utah, United States
- Hight Technology Hospital Medcenter Batumi, Georgia
NCT04937153
- Conditions
- Solid Tumor
- Locations
-
- National Cancer Center East Chiba, Japan
- National Cancer Center Hospital Tokyo, Japan
Completed
Technetium [99mTc]-H7ND in Patients With Gastrointestinal Malignancies and Healthy Volunteers
NCT06443710
- Conditions
- Solid Tumor
- Locations
-
- Zhongshan Hospital Affiliated to Fudan University Shanghai, China
Completed
A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
NCT05323045
- Conditions
- Solid Tumor
- Locations
-
- Institut Jules Bordet Brussels, Belgium
- Istituto Europeo di Oncologia Milan, Italy
- Radboud Nijmegen, Netherlands
- Royal Marsden London, United Kingdom
NCT03884556
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +27 more
- Locations
-
- UC Irvine Cancer Center Orange, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- University of California, San Francisco San Francisco, California, United States
- Sylvester Comprehensive Cancer Center Miami, Florida, United States
Completed
A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors
NCT04991506
- Conditions
- Malignant Tumor, Neoplasms, Solid Tumor
- Locations
-
- Jilin Cancer Hospital Changchun, Jilin, China
NCT07030439
- Conditions
- Solid Tumor
- Locations
-
- Xuzhou Central Hospital Xuzhou, Jiangsu, China
NCT04848493
- Conditions
- COVID-19, Connective Tissue Diseases, Coronaviridae Infections, +18 more
- Locations
-
- IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
- IRCCS Azienda Ospedaliera Universitaria Bologna, Bologhna, Italy
- Ospedale Policlinico San Martino IRCCS Genova, Italy
- Foindazione IRCCS Istituto Neurologico Carlo Besta Milan, Milano, Italy